Aerie withdraws Rhopressa NDA on manufacturing delay

Aerie Pharmaceuticals Inc. (NASDAQ:AERI) said it withdrew its NDA for Rhopressa netarsudil ophthalmic solution

Read the full 149 word article

How to gain access

Continue reading with a
two-week free trial.